The article presents the author's views on subtyping gastric cancer. It is stated that the DNA sequencing can directly pinpoint target molecules, which clinicians can use for individualized therapy in contrast to morphological classifications. A report published within the issue by Tomio Arai focuses on prevalence of microsatellite instability (MSI) in adenocarcinoma.